Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Boardley RL"'
Autor:
Lazaar AL; GSK R&D, King of Prussia, Pennsylvania, USA., Yang L; Experimental Medicine & Immunotherapeutics, Department of Medicine, University of Cambridge, and Cambridge Clinical Trials Unit, Cambridge., Boardley RL; GSK R&D, Stevenage, Cambridge and Ware., Goyal NS; GSK R&D, King of Prussia, Pennsylvania, USA., Robertson J; GSK R&D, Stevenage, Cambridge and Ware., Baldwin SJ; GSK R&D, Stevenage, Cambridge and Ware., Newby DE; University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK., Wilkinson IB; Experimental Medicine & Immunotherapeutics, Department of Medicine, University of Cambridge, and Cambridge Clinical Trials Unit, Cambridge., Tal-Singer R; GSK R&D, King of Prussia, Pennsylvania, USA., Mayer RJ; GSK R&D, King of Prussia, Pennsylvania, USA., Cheriyan J; Experimental Medicine & Immunotherapeutics, Department of Medicine, University of Cambridge, and Cambridge Clinical Trials Unit, Cambridge.; GSK R&D, Stevenage, Cambridge and Ware.; Cambridge University Hospitals NHS Foundation Trust, Cambridge and.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 May; Vol. 81 (5), pp. 971-9. Date of Electronic Publication: 2016 Jan 17.
Autor:
Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP; Neurosciences Therapeutic Area, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC, 27709, USA. conn.m.harrington@gsk.com.
Publikováno v:
Current Alzheimer research [Curr Alzheimer Res] 2014 Jan; Vol. 11 (1), pp. 47-58.